결핵 진단 시장 규모, 점유율, 예측 및 동향 분석 : 검사 유형별, 최종 사용자별, 감염 단계별 - 세계 예측(-2031년)
Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type (Mantoux, IGRA, Radiography Molecular Culture, Sputum Smear), End User (Hospital, Diagnostic Lab), Infection Stage - Global Forecast to 2031
상품코드 : 1504199
리서치사 : Meticulous Research
발행일 : On Demand Report
페이지 정보 : 영문 260 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,175 ₩ 6,038,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회만 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,875 ₩ 8,497,000
PDF (Multi User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,875 ₩ 11,389,000
PDF (Global Site License) help
PDF 보고서를 동일 기업 및 자회사의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

결핵 진단 시장은 2031년까지 35억 6,000만 달러에 달할 것으로 예상되며, 2024-2031년간 5.0%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 철저한 2차 및 1차 조사, 시장 시나리오에 대한 심층 분석에 이어 주요 시장 성장 촉진요인, 저해요인, 과제, 기회 및 동향에 대한 논의가 이어집니다.

중저소득 국가에서 결핵 유병률 증가, 약제 내성 균주의 출현, 결핵 진단 및 치료에 대한 긍정적인 접근이 이 시장의 성장을 주도하고 있습니다. 또한, 결핵에 대한 인식을 높이기 위한 정부 및 조직의 노력은 결핵 진단 시장에서 사업을 운영하는 기업에게 성장 기회를 제공할 것으로 예상됩니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

제5장 결핵 진단 시장 : 검사 유형별 평가

제6장 결핵 진단 시장 : 감염 스테이지별 평가

제7장 결핵 진단 시장 : 최종사용자별 평가

제8장 결핵 진단 시장 : 지역별 평가

제9장 경쟁 분석

제10장 기업 개요(사업 개요, 재무 개요, 제품 포트폴리오, 전략적 전개)

(주 : 주요 5개사의 SWOT 분석을 게재 예정)

제11장 부록

LSH
영문 목차

영문목차

Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type (Mantoux, IGRA, Radiography [X-ray, CT] Molecular [NAAT, WGS, Rapid] Culture, Sputum Smear), End User (Hospital, Diagnostic Lab), Infection Stage - Global Forecast to 2031

The tuberculosis diagnostics market is expected to reach $3.56 Billion by 2031, at a CAGR of 5.0% from 2024 to 2031. Following thorough secondary and primary research and in-depth analysis of the market scenario, the report discusses key industry drivers, restraints, challenges, opportunities, and trends

The growth of this market is driven by the rising prevalence of tuberculosis (TB) in low-and middle-income countries, the emergence of drug-resistant strains, and favorable initiatives for TB diagnosis and treatment. Moreover, initiatives by governments and organizations to raise awareness about tuberculosis are expected to generate growth opportunities for the players operating in the tuberculosis diagnostics market.

Based on test type, the market is segmented into skin test/Mantoux, radiographic tests, molecular tests, sputum smear microscopy, culture & drug resistance tests, and other test types. The molecular tests segment is projected to register the highest growth rate of 5.8% during the forecast period of 2024-2031. This segment's growth is driven by the high efficiency & accuracy of molecular tests, technological advancements in molecular diagnostic technology, increasing availability of molecular tests for TB, and initiatives by market players to introduce rapid molecular diagnostic tests for TB & drug resistance. Moreover, new guidelines by public organizations such as the WHO regarding molecular TB tests further drive the segment's growth. For instance, in March 2024, the WHO published recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of drug-resistant tuberculosis (TB).

Based on infection stage, the tuberculosis diagnostics market is segmented into active and latent. The active segment is expected to register the highest CAGR during the forecast period of 2024-2031. This growth can be attributed to the increasing prevalence of tuberculosis in low- and middle-income countries, aims and goals set by governments and public organizations to manage the TB burden, and growing instances of TB outbreaks.

Based on end user, the tuberculosis diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, academic & research institutes, and other end users. The diagnostic laboratories segment is expected to register the highest CAGR during the forecast period. This growth is driven by the increasing adoption of advanced technologies for TB diagnosis, including next-generation sequencing. Furthermore, diagnostic laboratories are more capable of investing in such technologies compared to clinics and small to medium-sized hospitals. Additionally, government and organizational initiatives aimed at raising awareness about tuberculosis further contribute to the segment's growth.

An in-depth analysis of the geographical scenario of the tuberculosis diagnostics market provides detailed qualitative and quantitative insights into five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 34.1% of the global tuberculosis diagnostics market, followed by Europe and Asia-Pacific.

However, the market in Asia-Pacific is projected to register the highest CAGR during the forecast period. Within Asia-Pacific, India and China are expected to present significant growth opportunities for players in the tuberculosis diagnostic market due to their large populations, high incidence of tuberculosis cases, and rising investments in healthcare. Additionally, the strong economic growth in both countries enables substantial investments in healthcare infrastructure and advancing tuberculosis testing technologies.

Key companies operating in the tuberculosis diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), Abbott Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN GmbH (Germany), Hologic, Inc. (U.S.), bioMerieux SA (France), Danaher Corporation (U.S.), Oxford Immunotec Ltd. (U.K.), Hain Lifescience GmbH (Germany), Creative Diagnostics (U.S.).

Scope of the Report:

Tuberculosis Diagnostics Market Assessment-by Test Type

(Note: Other Test Types include Urine Test, Breath Test, Cytokine Detection Assay, Cerebrospinal Fluid Test)

Tuberculosis Diagnostics Market Assessment-by Infection Stage

Tuberculosis Diagnostics Market Assessment-by End User

(Note: Other End Users include government, private organizations, and NGOs)

Tuberculosis Diagnostics Market Assessment-by Geography

TABLE OF CONTENTS

1. Overview

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Tuberculosis Diagnostics Market Assessment-by Test Type

6. Tuberculosis Diagnostics Market Assessment-by Infection Stage

7. Tuberculosis Diagnostics Market Assessment-by End User

8. Tuberculosis Diagnostics Market Assessment-by Geography

9. Competition Analysis

10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

(Note: SWOT analysis of the top 5 companies will be provided)

11. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기